SLC26 family: a new insight for kidney stone disease
- PMID: 37304821
- PMCID: PMC10247987
- DOI: 10.3389/fphys.2023.1118342
SLC26 family: a new insight for kidney stone disease
Abstract
The solute-linked carrier 26 (SLC26) protein family is comprised of multifunctional transporters of substrates that include oxalate, sulphate, and chloride. Disorders of oxalate homeostasis cause hyperoxalemia and hyperoxaluria, leading to urinary calcium oxalate precipitation and urolithogenesis. SLC26 proteins are aberrantly expressed during kidney stone formation, and consequently may present therapeutic targets. SLC26 protein inhibitors are in preclinical development. In this review, we integrate the findings of recent reports with clinical data to highlight the role of SLC26 proteins in oxalate metabolism during urolithogenesis, and discuss limitations of current studies and potential directions for future research.
Keywords: SLC26; hyperoxaluria; kidney stone; oxalate; oxalate metabolism.
Copyright © 2023 Li, Huang, Liu, Liao, Yan and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
The Handling of Oxalate in the Body and the Origin of Oxalate in Calcium Oxalate Stones.Urol Int. 2020;104(3-4):167-176. doi: 10.1159/000504417. Epub 2019 Dec 5. Urol Int. 2020. PMID: 31805567 Review.
-
Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G82-G94. doi: 10.1152/ajpgi.00299.2018. Epub 2018 Nov 1. Am J Physiol Gastrointest Liver Physiol. 2019. PMID: 30383413 Free PMC article.
-
The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.Urolithiasis. 2017 Feb;45(1):89-108. doi: 10.1007/s00240-016-0952-z. Epub 2016 Dec 2. Urolithiasis. 2017. PMID: 27913853 Free PMC article. Review.
-
SLC26 chloride/base exchangers in the kidney in health and disease.Semin Nephrol. 2006 Sep;26(5):375-85. doi: 10.1016/j.semnephrol.2006.07.005. Semin Nephrol. 2006. PMID: 17071331 Review.
-
Renal physiology of SLC26 anion exchangers.Curr Opin Nephrol Hypertens. 2007 Sep;16(5):484-90. doi: 10.1097/MNH.0b013e3282e7d7d0. Curr Opin Nephrol Hypertens. 2007. PMID: 17693766 Review.
Cited by
-
Gene-Expression Patterns of Tumor and Peritumor Tissues of Smoking and Non-Smoking HPV-Negative Patients with Head and Neck Squamous Cell Carcinoma.Biomedicines. 2024 Mar 21;12(3):696. doi: 10.3390/biomedicines12030696. Biomedicines. 2024. PMID: 38540309 Free PMC article.
-
Enhancer Profiling Reveals a Protective Role of RXRα Against Calcium Oxalate-Induced Crystal Deposition and Kidney Injury.Adv Sci (Weinh). 2025 Jun;12(21):e2411735. doi: 10.1002/advs.202411735. Epub 2025 Mar 17. Adv Sci (Weinh). 2025. PMID: 40091688 Free PMC article.
-
Mechanisms and physiological relevance of acid-base exchange in functional units of the kidney.PeerJ. 2024 Apr 29;12:e17316. doi: 10.7717/peerj.17316. eCollection 2024. PeerJ. 2024. PMID: 38699185 Free PMC article. Review.
-
Balancing Stone Prevention and Kidney Function: A Therapeutic Dilemma.J Clin Med. 2025 May 23;14(11):3678. doi: 10.3390/jcm14113678. J Clin Med. 2025. PMID: 40507440 Free PMC article. Review.
-
The enigmatic SLC26A6 multifunctional anion transporter: recent advances in structure-function relationship, pathophysiological significance and novel pharmacological inhibitors.Front Pharmacol. 2025 Jan 30;15:1536864. doi: 10.3389/fphar.2024.1536864. eCollection 2024. Front Pharmacol. 2025. PMID: 39949394 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources